00

Zhuhai Rundu Pharmaceutical Co LtdSHE 002923 Stock Report

Last reporting period 30 Sep, 2023

Updated 08 Nov, 2024

Last price

Market cap $B

0.407

Micro

Exchange

XSHE - Shenzhen Stock Exchange

002923.SZ Stock Analysis

00

Avoid

Based on Eyestock quantitative analysis, 002923.SZ`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

41/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-3.9 %

Overvalued

Market cap $B

0.407

Dividend yield

1.87 %

Shares outstanding

239.21 B

Zhuhai Rundu Pharmaceutical Co., Ltd. engages in the manufacture, research and development, and marketing of pharmaceutical drugs. The company is headquartered in Zhuhai, Guangdong and currently employs 1,594 full-time employees. The company went IPO on 2018-01-05. The Company’s products cover the fields of cardio-cerebral blood vessels, digestion and anesthesia, among others.

View Section: Eyestock Rating